Noland Arbaugh spoke to Euronews Next about what he has been doing since the brain implant and his hopes for the future. View ...

Neuralink, the medical implant company founded by Elon Musk, says a second patient made impressive progress by controlling a computer minutes after the implant was turned on, just weeks after it ...

At the time, Musk said 400 of the implant's electrodes on the second patient's brain were working. The threads have more than 1,000 electrodes in total. Neuralink aims to eventually create a ...

Alex’s implant marks the second time Neuralink has successfully implanted its BCI into a patient. Earlier this year, Neuralink implanted it into Noland Arbaugh, a quadriplegic. According to the ...

The second human with a Neuralink brain chip is using the implant to play the PC game Counter-Strike 2. Elon Musk’s company gave a progress update on Wednesday about on its second patient ...

Neuralink continues to make progress with its brain-implant device, as it has successfully placed the device into another human. The company shared an update on its second human patient – Alex ...

The second patient in Neuralink's PRIME Study underwent brain implant surgery in July 2024. The patient, named Alex, underwent surgery at the Barrow Neurological Institute, was discharged the next ...

Aug 21 (Reuters) - Elon Musk's brain technology startup Neuralink said its implant, designed to allow paralyzed patients to use digital devices by thinking alone, is working well in a second trial ...

Musk's Neuralink Says Second Trial Implant Went Well, No Thread Retraction Issue (Reuters) - Elon Musk's brain technology startup Neuralink said its implant, designed to allow paralyzed patients ...

The second human with a Neuralink brain chip is using the implant to play the PC game Counter-Strike 2. Elon Musk’s company gave a progress update on Wednesday about on its second patient “Alex,” who ...

Elon Musk's brain technology startup Neuralink said its implant, designed to allow paralysed patients to use digital devices by thinking alone, is working well in a second trial patient.